Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
Journal of Internal Medicine
|
February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy
J A C Sterne, M May, H C Bucher, et al.
HIV Medicine
|
April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study
H Kovari, B Surial, P E Tarr, et al.
JAMA
|
April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group
J D Lundgren, A N Phillips, C Pedersen, et al.
Lancet (London, England)
|
July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A Mocroft, A N Phillips, J Gatell, et al.
BMJ (Clinical Research Ed.)
|
April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group
J D Lundgren, C Pedersen, N Clumeck, et al.
HIV Medicine
|
March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change
J Reekie, A Mocroft, B Ledergerber, et al.
HIV Medicine
|
August 16, 2014
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study
R Weber, M Huber, M Battegay, et al.
Archives of Internal Medicine
|
July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
R Weber, B Ledergerber, R Zbinden, et al.
HIV Medicine
|
September 8, 2009
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)
A U Scherrer, B Hasse, V von Wyl, et al.
Lancet (London, England)
|
October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, K Boubaker, B Ledergerber, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
Journal of Internal Medicine
|
February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy
J A C Sterne, M May, H C Bucher, et al.
HIV Medicine
|
April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study
H Kovari, B Surial, P E Tarr, et al.
JAMA
|
April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group
J D Lundgren, A N Phillips, C Pedersen, et al.
Lancet (London, England)
|
July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A Mocroft, A N Phillips, J Gatell, et al.
BMJ (Clinical Research Ed.)
|
April 23, 1994
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group
J D Lundgren, C Pedersen, N Clumeck, et al.
HIV Medicine
|
March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change
J Reekie, A Mocroft, B Ledergerber, et al.
HIV Medicine
|
August 16, 2014
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study
R Weber, M Huber, M Battegay, et al.
Archives of Internal Medicine
|
July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study
R Weber, B Ledergerber, R Zbinden, et al.
HIV Medicine
|
September 8, 2009
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)
A U Scherrer, B Hasse, V von Wyl, et al.
Lancet (London, England)
|
October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, K Boubaker, B Ledergerber, et al.
Page
of 12